Making AI-Powered Healthcare Mainstream: What the Health Tech Investment Act (S.1399) Means for AI-Device Developers
By- Anya Bekhtel (Mittal Consulting) Artificial intelligence and machine learning are driving innovation throughout healthcare, creating opportunities for faster and more accessible treatment solutions. While the FDA has authorized hundreds of AI and ML enabled...
What We’re Expecting to See at MedTech World Bay Area 2025
WHAT : Medtech World Bay Area Event WHERE : Signia Hotel by Hilton, San Jose 170 S Market St, San Jose, CA 95113 WHEN: June 27th, 2025 MedTech World Bay Area 2025 is just around the corner, and as the premiere regulatory affairs partner for startups in...
FDA Revamps Q-Sub Process with New Guidance and Digital Submission Template
By- Elle Winn (Mittal Consulting) FDA Revamps Q-Sub Process with New Guidance and Digital Submission Template On May 29, 2025, the U.S. Food and Drug Administration (FDA) released two significant guidances related to the Q-Submission (Q-Sub) Program for medical...
Siloam Vision Earns Breakthrough Device Designation for OCT Technology Aimed at Preventing Infant Blindness
May 14, 2025 Since 2021, Siloam Vision has been pioneering clinical solutions to prevent blindness and improve global vision health. Retinopathy of Prematurity (ROP) is a leading global cause of permanent infant blindness, particularly in regions with limited access...